abstract |
FIELD: pharmacy. n SUBSTANCE: invention relates to a compound or a pharmaceutically acceptable salt thereof, having the following structure: n n n n The invention also relates to other individual compounds and pharmaceutically acceptable salts thereof, the structural formulas of which are indicated in the claims, a pharmaceutical composition for HIV replication inhibition and to a method for HIV infection treatment. n EFFECT: new propenoate betulin derivatives are obtained, that inhibit HIV replication. n 20 cl, 2 tbl, 35 ex |